HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

relmapirazin

fluorescent tracer agent

Also Known As:

3,6-diamino-2,5-bis(N-((1R)-1-carboxy-2 hydroxyethyl)carbamoyl)pyrazine; MB-102

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrazines: 150
    - relmapirazin: 3

Experts

1.	Bugaj, Joseph E: 1 article (10/2019)
2.	Dorshow, Richard B: 1 article (10/2019)

Related Diseases

1.	Critical Illness (Critically Ill) 01/01/2023 - "We suggest transdermal MB-102 clearance provides real-time personalized assessment of drug elimination and could optimize prescription of drugs for critically ill patients requiring CRRT." 01/01/2023 - "Hence MB-102 CLTM should be measurable for critically ill patients receiving CRRT."
2.	Inflammation (Inflammations) 10/01/2019 - "A single dose of MB-102 administered either intravenously (18.6 mg/mL) or perivenously (0.25 mL) was well-tolerated in NZ white rabbits, with no adverse inflammation or irritation. "